KMTS - רווח למניה בשנים עשר החודשים האחרונים Kestra Medical Technologies, Inc.

Kestra Medical Technologies focuses its cardio-monitoring production in the US, as confirmed by the current trailing twelve-month net income per share in the GURU.Markets terminal, where -2.64 determines this parameter level. Revenues are based on the sale and service of wearable defibrillators. Capital inflow is supported by the stable leasing of modern devices, which have become an efficient cash cow for the company.

Professional capital evaluates the efficiency of Kestra Medical Technologies (KMTS) through earnings per share, which allows for the exclusion of the impact of share issuance on the business's real income. Analyzing this 12-month earnings per share chart, an investor can see how partnerships in the wearable defibrillator sector convert into capitalization, determining the asset's fundamental stability.